mlsanityData to 14 Oct 2026

AOP-Wiki EMOD 3.0: Data Model Expansions and Content Evaluation Framework for Using Agentic AI to Improve Integration between AOPs and New Approach Methodologies (NAMs)

arXiv 2605.21645 ↗First posted 20 May 2026cs.AI cs.DBcited by 0

On the map: LLM agents and tool use → Medical and scientific domain agents

Abstract (arXiv)

Adverse Outcome Pathways (AOP) are logic models that causally link biological mechanisms that can be measured in a lab to adverse outcomes, relevant to chemical regulatory endpoints. AOPs contextualize new approach methodologies (NAMs), in vitro and in silico methods used as alternatives to animal testing and the sequential events in an AOP serve as multi-scale models spanning biological scales. The AOP-Wiki serves as the global repository for AOPs. While the AOP-Wiki has played a central role in AOP expansion over the past decade, constraints within the current data model and application infrastructure limit the AOP-Wiki from supporting continued AOP growth and evolution. Yet, the transformative power of agentic AI has re-invigorated AOP-Wiki data modernization efforts at a time when core AOP principles can be harnessed to inform use of AI for aggregating and structuring AOP-relevant information. Seizing upon this momentum, we present AOP-Wiki EMOD 3.0, the third in a series of evidence model prototypes, which concretely demonstrates data model expansions and our vision for how the AOP-Wiki might be transformed to better serve regulatory science and emergent use of AOPs in biomedical and One Health contexts. We aim to lay a foundation to support computationally-generated AOPs and quantitative AOPs (qAOPs) by focussing on solutions for AOP-Wiki internal quality improvement, evidence structuring to enhance AOP FAIRness and AI-readiness, and improved integration between the AOP framework and NAMs to better serve next generation risk assessment.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 0 of its 45 references that are in the map. First posted on arXiv 20 May 2026.

Builds on

0 of 45 references.

No references here yet.

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2026AOP-Smart: A RAG-Enhanced Large Language Model Framework for Adverse Outcome Pathway Analysis
  2. 2026FastOMOP: A Foundational Architecture for Reliable Agentic Real-World Evidence Generation on OMOP CDM data
  3. 2026APOD: reasoning-guided agentic population ordinary differential equation discovery for pharmacological digital twins
  4. 2026ToxReason: A Benchmark for Mechanistic Chemical Toxicity Reasoning via Adverse Outcome Pathway
  5. 2025BioinfoMCP: A Unified Platform Enabling MCP Interfaces in Agentic Bioinformatics
  6. 2026NVAITC AI Scientist: A Governed End-to-End Research System -- A Hypertension GWAS Case Study
  7. 2025An Agentic Model Context Protocol Framework for Medical Concept Standardization
  8. 2026Measuring Biological Capabilities and Risks of AI Agents